McDonald-McGinn DM, Emanuel BS, Zackai EH. 22q11.2 Deletion Syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, et al., editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle; 1999. http://www.ncbi.nlm.nih.gov/books/NBK1523/.
Grati FR, Molina Gomes D, Ferreira JCPB, Dupont C, Alesi V, Gouas L, et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn. 2015;35:801–9.
Article
PubMed
Google Scholar
McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, et al. The Philadelphia Story: the 22q11. 2 deletion: report on 250 patients. Genet Couns Geneva Switz. 1999;10:11–24.
CAS
Google Scholar
Wentzel C, Fernström M, Öhrner Y, Annerén G, Thuresson A-C. Clinical variability of the 22q11. 2 duplication syndrome. Eur J Med Genet. 2008;51:501–10.
Article
PubMed
Google Scholar
Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007;370:1443–52.
Article
CAS
PubMed
Google Scholar
Wenger TL, Miller JS, DePolo LM, de Marchena AB, Clements CC, Emanuel BS, et al. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening. Mol Autism. 2016;7 doi:10.1186/s13229-016-0090-z.
Schneider M, Debbané M, Bassett AS, Chow EWC, Fung WLA, van den Bree M, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171:627–39.
Article
PubMed
PubMed Central
Google Scholar
Hoeffding LK, Trabjerg BB, Olsen L, Mazin W, Sparsø T, Vangkilde A, et al. Risk of psychiatric disorders among individuals with the 22q11.2 deletion or duplication: a danish nationwide, register-based study. JAMA Psychiatry. 2017;74:282–90.
Article
PubMed
Google Scholar
Rees E, Kirov G, Sanders A, Walters JTR, Chambert KD, Shi J, et al. Evidence that duplications of 22q11. 2 protect against schizophrenia. Mol Psychiatry. 2014;19:37.
Article
CAS
PubMed
Google Scholar
Vorstman JAS, Morcus MEJ, Duijff SN, Klaassen PWJ, Heineman-de Boer JA, Beemer FA, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry. 2006;45:1104–13.
Article
PubMed
Google Scholar
Ousley O, Evans AN, Fernandez-Carriba S, Smearman EL, Rockers K, Morrier MJ, et al. Examining the overlap between autism spectrum disorder and 22q11.2 deletion syndrome. Int J Mol Sci. 2017;18:1071.
Article
PubMed Central
Google Scholar
Angkustsiri K, Goodlin-Jones B, Deprey L, Brahmbhatt K, Harris S, Simon TJ. Social impairments in chromosome 22q11.2 deletion syndrome (22q11.2DS): autism spectrum disorder or a different endophenotype? J Autism Dev Disord. 2014;44:739–46.
Article
PubMed
PubMed Central
Google Scholar
Michaelovsky E, Frisch A, Carmel M, Patya M, Zarchi O, Green T, et al. Genotype-phenotype correlation in 22q11. 2 deletion syndrome. BMC Med Genet. 2012;13:122.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bengoa-Alonso A, Artigas-Lopez M, Moreno-Igoa M, Cattalli C, Hernandez-Charro B, Ramos-Arroyo MA. Delineation of a recognizable phenotype for the recurrent LCR22-C to D/E atypical 22q11.2 deletion. Am J Med Genet A. 2016;170:1485–94.
Article
CAS
PubMed
Google Scholar
Guris DL, Fantes J, David T, Druker BJ, Imamoto A. Mice lacking the homologue of the human 22q11. 2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet. 2001;27:293.
Article
CAS
PubMed
Google Scholar
Lindsay EA, Vitelli F, Su H, Morishima M, et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature. 2001;410:97.
Article
CAS
PubMed
Google Scholar
Guo T, McDonald-McGinn D, Blonska A, Shanske A, Bassett AS, Chow E, et al. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/digeorge/22q11. 2 deletion syndrome patients. Hum Mutat. 2011;32:1278–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jerome LA, Papaioannou VE. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet. 2001;27:286–91.
Article
CAS
PubMed
Google Scholar
Herman SB, Guo T, McGinn DMM, Blonska A, Shanske AL, Bassett AS, et al. Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11. 2 deletion syndrome patients. Am J Med Genet A. 2012;158:2781–7.
Article
CAS
Google Scholar
Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet. 2006;16:83–91.
Article
PubMed
Google Scholar
Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, et al. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry. 2005;10:479.
Article
CAS
PubMed
Google Scholar
Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11. 2 deletion syndrome. Nat Neurosci. 2005;8:1500.
Article
CAS
PubMed
Google Scholar
Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, et al. Proline affects brain function in 22q11DS children with the low activity COMT158 allele. Neuropsychopharmacology. 2009;34:739.
Article
CAS
PubMed
Google Scholar
Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EW. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry. 2007;61:1135–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baker K, Baldeweg T, Sivagnanasundaram S, Scambler P, Skuse D. COMT Val 108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry. 2005;58:23–31.
Article
CAS
PubMed
Google Scholar
Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940–5.
Article
CAS
PubMed
Google Scholar
Bassett AS, Chow EW. Schizophrenia and 22q11. 2 deletion syndrome. Curr Psychiatry Rep. 2008;10:148.
Article
PubMed
PubMed Central
Google Scholar
Radoeva PD, Coman IL, Salazar CA, Gentile KL, Higgins AM, Middleton FA, et al. Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes. Psychiatr Genet. 2014;24:269–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hidding E, Swaab H, Sonneville LMJ, Engeland H, Vorstman J a S. The role of COMT and plasma proline in the variable penetrance of autistic spectrum symptoms in 22q11.2 deletion syndrome. Clin Genet. 2016;90:420–7.
Article
CAS
PubMed
Google Scholar
Wenger TL, Kao C, McDonald-McGinn DM, Zackai EH, Bailey A, Schultz RT, et al. The role of mGluR copy number variation in genetic and environmental forms of syndromic autism spectrum disorder. Sci Rep. 2016;6:19372.
Article
CAS
PubMed
PubMed Central
Google Scholar
Snyder LG, D’Angelo D, Chen Q, Bernier R, Goin-Kochel RP, Wallace AS, et al. Autism spectrum disorder, developmental and psychiatric features in 16p11. 2 duplication. J Autism Dev Disord. 2016;46:2734–48.
Article
Google Scholar
Fuchs-Telem D, Stewart H, Rapaport D, Nousbeck J, Gat A, Gini M, et al. CEDNIK syndrome results from loss-of-function mutations in SNAP29. Br J Dermatol. 2011;164:610–6.
CAS
PubMed
Google Scholar
D’Angelo D, Lebon S, Chen Q, Martin-Brevet S, Snyder LG, Hippolyte L, et al. Defining the effect of the 16p11. 2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry. 2016;73:20–30.
Article
PubMed
Google Scholar
Dudova I, Markova D, Kasparova M, Zemankova J, Beranova S, Urbanek T, et al. Comparison of three screening tests for autism in preterm children with birth weights less than 1,500 grams. Neuropsychiatr Dis Treat. 2014;10:2201.
Article
PubMed
PubMed Central
Google Scholar
Lord C, Rutter M, DiLavore PC, Risi S. Autism diagnostic observation schedule (ADOS). Los Angeles, CA: Western Psychological Services; 1999.
Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Google Scholar
Sparrow SS, Cicchetti DV, Balla DA. Vineland adaptive behavior scales, 2nd edition (Vineland II): survey interview form/caregiver rating form. Livonia, MN: Pearson Assessments; 2005.
Google Scholar
Gadow KD, Sprafkin J. Child and adolescent symptom inventory-4R. Stony Brook, NY: Checkmate Plus; 2005.
Google Scholar
Rutter M, Bailey A, Lord C. The Social Communication Questionnaire. Los Angeles, CA: Western Psychological Services; 2003.
Google Scholar
Constantino JN, Gruber CP. Social Responsiveness Scale (SRS). Torrance, CA: Western Psychological Services; 2012.
Google Scholar
Constantino JN, Gruber CP. Social Responsiveness Scale, 2nd edition (SRS-2). Los Angeles, CA: Western Psychological Services; 2012.
Google Scholar
Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14:365–76.
Article
CAS
PubMed
Google Scholar
Cumming G. The new statistics: why and how. Psychol Sci. 2014;25:7–29.
Article
PubMed
Google Scholar
Hadley D, Wu Z, Kao C, Kini A, Mohamed-Hadley A, Thomas K, et al. The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. Nat Commun. 2014;5 doi:10.1038/ncomms5074.
Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature. 2011;480:63–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jennifer L Ingram, Stacey M Peckham, Barbara Tisdale, Patricia M Rodier, (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicology and Teratology 22(3):319-324.
Jakob Christensen, Therese Koops Grønborg, Merete Juul Sørensen, Diana Schendel, Erik Thorlund Parner, Lars Henning Pedersen, Mogens Vestergaard, (2013) Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism. JAMA 309 (16):1696.
Kesavan Meganathan, Smita Jagtap, Vilas Wagh, Johannes Winkler, John Antonydas Gaspar, Diana Hildebrand, Maria Trusch, Karola Lehmann, Jürgen Hescheler, Hartmut Schlüter, Agapios Sachinidis, Yao Liang Tang, (2012) Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells. PLoS ONE 7 (8):e44228.
Meechan DW, Maynard TM, Wu Y, Gopalakrishna D, Lieberman JA, LaMantia A-S. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. Mol Cell Neurosci. 2006;33:412–28.
Article
CAS
PubMed
Google Scholar
Paronett EM, Meechan DW, Karpinski BA, LaMantia A-S, Maynard TM. Ranbp1, deleted in DiGeorge/22q11.2 deletion syndrome, is a microcephaly gene that selectively disrupts layer 2/3 cortical projection neuron generation. Cereb Cortex. 2015;25:3977–93.
Article
PubMed
Google Scholar
Meechan DW, Tucker ES, Maynard TM, LaMantia A-S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc Natl Acad Sci. 2009;106:16434–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang MS, Arnaoutov A, Dasso M. RanBP1 governs spindle assembly by defining mitotic Ran-GTP production. Dev Cell. 2014;31:393–404.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weisfeld-Adams JD, Edelmann L, Gadi IK, Mehta L. Phenotypic heterogeneity in a family with a small atypical microduplication of chromosome 22q11.2 involving TBX1. Eur J Med Genet. 2012;55:732–6.
Article
PubMed
Google Scholar
Cohen J. The effect size. Stat Power Anal Behav Sci. 1988;2:284–8.
Google Scholar